DrugRepV Browse Page


DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Antiparasitic products, Insectisides and Repellents are 465




DrugRepV_ID Antiviral Name
Drug type
Primary Indication
Secondary Indication
Strain
Pathways
Assay
Activity
Clinical Status
References
DrugRepV_0001Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
Brazilian strain ZKV2015
NA
Immunoflourescence assay
Decrease (50 %)
Approved
29150641
DrugRepV_0002Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
Brazilian strain ZKV2015
NA
NA
Decrease
Approved
29150641
DrugRepV_0003Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
Brazilian strain ZKV2015
NA
Real-time PCR
Decrease (20 Fold)
Approved
29150641
DrugRepV_0004Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
Brazilian strain ZKV2015
NA
Immunohistochemical assay
Decrease (10 %)
Approved
29150641
DrugRepV_0005Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
GZ01, a recent Asian lineage
NA
Plaque assay
Decrease (100 %)
Approved
29033372
DrugRepV_0007Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
GZ01, a recent Asian lineage
NA
Plaque assay
Decrease (60 %)
Approved
29033372
DrugRepV_0021Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
GZ01, a recent Asian lineage
NA
Real-time PCR
Decrease (50 %)
Approved
29033372
DrugRepV_0022Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
GZ01, a recent Asian lineage
NA
Real-time PCR
Decrease (50 %)
Approved
29033372
DrugRepV_0023Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
FSS13025 strain (old Asian lineage)
NA
Real-time PCR
Decrease (50 %)
Approved
29033372
DrugRepV_0024Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
GZ01, a recent Asian lineage
NA
Real-time PCR
Decrease (2 Copies (10(6)/ml))
Approved
29033372
DrugRepV_0025Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
GZ01, a recent Asian lineage
NA
Real-time PCR
Decrease (1 Copies (10(6)/ml))
Approved
29033372
DrugRepV_0026Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
GZ01, a recent Asian lineage
NA
NA
Decrease
Approved
29033372
DrugRepV_0027Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
GZ01, a recent Asian lineage
NA
Immunohistochemical assay
Decrease (85 %)
Approved
29033372
DrugRepV_0028Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A(H1N1)pdm09
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0029Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A(H3N2)
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0030Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
B (Victoria lineage)
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0031Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
B (Yamagata lineage)
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0032Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A(H1N1)pdm09/A/Sydney/185/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0033Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A(H1N1)pdm09/A/Singapore/TT1275/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0034Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A(H1N1)pdm09/A/Sydney/158/2016
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0035Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A(H1N1)pdm09/A/Victoria/2500/2016
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0036Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A(H1N1)pdm09 /A/Malaysia/2/2014
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0037Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A(H3N2) /A/Victoria/1031/2010
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0038Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A(H3N2) /A/Victoria/1035/2010
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0039Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A(H3N2) /A/Victoria/92/2012
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0040Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A(H3N2) /A/Malaysia/22/2013
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0041Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A(H3N2) /A/Sydney/236/2014
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0042Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
B/ B/South Australia/2/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0043Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
B/ B/Canberra/1/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0044Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
B/ B/South Australia/5/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0045Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
B/ B/Perth/136/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0102Flubendazole
Antiparasitic products, Insectisides and Repellents
Helminthiasis
Zika virus
Mex2-81
NA
Immunoflourescence assay
Decrease (50 %)
Experimental, Withdrawn
28099856
DrugRepV_0104Albendazole
Antiparasitic products, Insectisides and Repellents
Parasitic infections
Zika virus
Mex2-81
NA
Immunoflourescence assay
No significant effect
Approved
28099856
DrugRepV_0119Albendazole
Antiparasitic products, Insectisides and Repellents
Parasitic infections
Zika virus
Mex2-81
NA
Immunoflourescence assay
Decrease (50 %)
Approved
28099856
DrugRepV_0199Chloroquine
Antiparasitic products, Insectisides and Repellents
malaria
Ebola virus
VLP
NA
Immunoflourescence assay
Decrease (50 %)
Approved
27890675
DrugRepV_0201Mefloquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
VLP
NA
Immunoflourescence assay
Decrease (50 %)
Approved, Investigational
27890675
DrugRepV_0210Mefloquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
EBOLA/Mayinga-eGFP
NA
Immunoflourescence assay
Decrease (50 %)
Approved, Investigational
27890675
DrugRepV_0317Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Ebola virus
EBOV-eGFP
NA
Immunoflourescence assay
Decrease (50 %)
Approved, Investigational, Vet approved
27622822
DrugRepV_0318Mebendazole
Antiparasitic products, Insectisides and Repellents
Helminthiasis (Enterobius vermicularis (pinworm), Trichuris trichiura (whipworm), Ascaris lumbricoides (common roundworm), Ancylostoma duodenale (common hookworm), Necator americanus (American hookworm) in single or mixed infections)
Ebola virus
EBOV-eGFP
NA
Immunoflourescence assay
Decrease (50 %)
Approved, Vet approved
27622822
DrugRepV_0325Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
EBOV-eGFP
NA
Immunoflourescence assay
Decrease (50 %)
Approved
27622822
DrugRepV_0326Hydroxychloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
EBOV-eGFP
NA
Immunoflourescence assay
Decrease (50 %)
Approved
27622822
DrugRepV_0327Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
EBOV-eGFP
NA
Immunoflourescence assay
Decrease (50 %)
Approved
27622822
DrugRepV_0338Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Ebola virus
Ebola Zaire glycoprotein pseudotype vesicular stomatitis virus
NA
Renilla luciferase assay
Decrease (50 %)
Approved
27622822
DrugRepV_0339Mebendazole
Antiparasitic products, Insectisides and Repellents
Helminthiasis (Enterobius vermicularis (pinworm), Trichuris trichiura (whipworm), Ascaris lumbricoides (common roundworm), Ancylostoma duodenale (common hookworm), Necator americanus (American hookworm) in single or mixed infections)
Ebola virus
Ebola Zaire glycoprotein pseudotype vesicular stomatitis virus
NA
Renilla luciferase assay
Decrease (50 %)
Approved, Vet approved
27622822
DrugRepV_0345Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
Ebola Zaire glycoprotein pseudotype vesicular stomatitis virus
NA
Renilla luciferase assay
Decrease (50 %)
Approved
27622822
DrugRepV_0346Hydroxychloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
Ebola Zaire glycoprotein pseudotype vesicular stomatitis virus
NA
Renilla luciferase assay
Decrease (50 %)
Approved
27622822
DrugRepV_0347Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
Ebola Zaire glycoprotein pseudotype vesicular stomatitis virus
NA
Renilla luciferase assay
Decrease (50 %)
Approved
27622822
DrugRepV_0355Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
Ebola Zaire
NA
Survival assay
Increase
Approved
27622822
DrugRepV_0356Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
Ebola Zaire
NA
Survival assay
No significant effect
Approved
27622822
DrugRepV_0358Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
Ebola Zaire
NA
Survival assay
No significant effect
Approved
27622822
DrugRepV_0367Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
Ebola Mayinga
NA
Survival assay
No significant effect
Approved
27622822
DrugRepV_0393Mebendazole
Antiparasitic products, Insectisides and Repellents
Helminthiasis (Enterobius vermicularis (pinworm), Trichuris trichiura (whipworm), Ascaris lumbricoides (common roundworm), Ancylostoma duodenale (common hookworm), Necator americanus (American hookworm) in single or mixed infections)
Ebola virus
eGFP-EBOV
NA
Fluorescence-based assay
Decrease (50 %)
Approved, Vet approved
26041706
DrugRepV_0397Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Ebola virus
eGFP-EBOV
NA
Fluorescence-based assay
Decrease (50 %)
Approved
26041706
DrugRepV_0400Pentamidine
Antiparasitic products, Insectisides and Repellents
Pneumonia
Ebola virus
eGFP-EBOV
NA
Fluorescence-based assay
Decrease (50 %)
Approved, Investigational
26041706
DrugRepV_0405Pyrvinium Pamoate
Antiparasitic products, Insectisides and Repellents
Pinworm infestations
Ebola virus
eGFP-EBOV
NA
Fluorescence-based assay
Decrease (50 %)
Approved
26041706
DrugRepV_0423Atovaquone
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
eGFP-EBOV
NA
Fluorescence-based assay
Decrease (50 %)
Approved
26041706
DrugRepV_0479Atovaquone
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
EBOV-VLP
NA
Flow cytometry
No significant effect
Approved
26041706
DrugRepV_0535Mebendazole
Antiparasitic products, Insectisides and Repellents
Helminthiasis (Enterobius vermicularis (pinworm), Trichuris trichiura (whipworm), Ascaris lumbricoides (common roundworm), Ancylostoma duodenale (common hookworm), Necator americanus (American hookworm) in single or mixed infections)
Ebola virus
EBOVBlaVP40
NA
Fluorescence-based assay
Decrease (50 %)
Approved, Vet approved
26038505
DrugRepV_0538Albendazole
Antiparasitic products, Insectisides and Repellents
Parasitic infections
Ebola virus
EBOVBlaVP40
NA
Fluorescence-based assay
Decrease (50 %)
Approved
26038505
DrugRepV_0548Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Ebola virus
EBOVBlaVP40
NA
Fluorescence-based assay
Decrease (50 %)
Approved
26038505
DrugRepV_0550Mefloquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
EBOVBlaVP40
NA
Fluorescence-based assay
Decrease (50 %)
Approved, Investigational
26038505
DrugRepV_0558Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
EBOVBlaVP40
NA
Fluorescence-based assay
Decrease (50 %)
Approved
26038505
DrugRepV_0572Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
EBOVBlaVP40
NA
Fluorescence-based assay
Decrease (50 %)
Approved
26038505
DrugRepV_0574Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Crimean-Congo hemorrhagic fever virus
IbAr10200, Nigeria
NA
Plaque assay
Decrease (50 %)
Approved
25796972
DrugRepV_0575Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Crimean-Congo hemorrhagic fever virus
ArD39554
NA
Plaque assay
Decrease (50 %)
Approved
25796972
DrugRepV_0576Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Crimean-Congo hemorrhagic fever virus
IbAr10200, Nigeria
NA
Plaque assay
Decrease (50 %)
Approved
25796972
DrugRepV_0606Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Lassa virus
GP derived Pseudovirus
NA
Luciferase reporter assay
Decrease (51 %)
Approved
23577127
DrugRepV_0609Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Lassa virus
GP derived Pseudovirus
NA
Luciferase reporter assay
Decrease (34 %)
Approved
23577127
DrugRepV_0629Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Lassa virus
Josiah
NA
Real-time PCR
No significant effect
Approved
23577127
DrugRepV_0632Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Lassa virus
Josiah
NA
Real-time PCR
No significant effect
Approved
23577127
DrugRepV_0645Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Marburg virus
GP derived Pseudovirus
NA
Luciferase reporter assay
Decrease (97 %)
Approved
23577127
DrugRepV_0648Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Marburg virus
GP derived Pseudovirus
NA
Luciferase reporter assay
Decrease (97 %)
Approved
23577127
DrugRepV_0669Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
GP derived Pseudovirus
NA
Luciferase reporter assay
Decrease (99 %)
Approved
23577127
DrugRepV_0672Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
GP derived Pseudovirus
NA
Luciferase reporter assay
Decrease (97 %)
Approved
23577127
DrugRepV_0692Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
EBOLA-eGFP
NA
Fluorescence-based assay
No significant effect
Approved
23577127
DrugRepV_0695Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
EBOLA-eGFP
NA
Fluorescence-based assay
Decrease
Approved
23577127
DrugRepV_0709Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Marburg virus
GP derived Pseudovirus
NA
Luciferase reporter assay
Decrease (50 %)
Approved
23577127
DrugRepV_0710Hydroxychloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Marburg virus
GP derived Pseudovirus
NA
Luciferase virus entry activity
Decrease (50 %)
Approved
23577127
DrugRepV_0711Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Marburg virus
GP derived Pseudovirus
NA
Luciferase reporter assay
Decrease (50 %)
Approved
23577127
DrugRepV_0713Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Marburg virus
Musoke
NA
Immunoflourescence assay
Decrease (50 %)
Approved
23577127
DrugRepV_0714Hydroxychloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Marburg virus
Musoke
NA
Immunoflourescence assay
Decrease (50 %)
Approved
23577127
DrugRepV_0715Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Marburg virus
Musoke
NA
Immunoflourescence assay
Decrease (50 %)
Approved
23577127
DrugRepV_0717Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
GP derived Pseudovirus
NA
Luciferase reporter assay
Decrease (50 %)
Approved
23577127
DrugRepV_0718Hydroxychloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
GP derived Pseudovirus
NA
Luciferase reporter assay
Decrease (50 %)
Approved
23577127
DrugRepV_0719Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
GP derived Pseudovirus
NA
Luciferase reporter assay
Decrease (50 %)
Approved
23577127
DrugRepV_0721Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
EBOLA-eGFP
NA
Fluorescence-based assay
Decrease (50 %)
Approved
23577127
DrugRepV_0722Hydroxychloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
EBOLA-eGFP
NA
Fluorescence-based assay
Decrease (50 %)
Approved
23577127
DrugRepV_0723Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
EBOLA-eGFP
NA
Fluorescence-based assay
Decrease (50 %)
Approved
23577127
DrugRepV_0726Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
ma-EBOV
NA
NA
Increase
Approved
23577127
DrugRepV_0764Ivermectin
Antiparasitic products, Insectisides and Repellents
Intestinal strongyloidiasis | Onchocerciasis
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (99.52 %)
Approved, Investigational, Vet approved
27476412
DrugRepV_0765Mefloquine Hydrochloride
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (99.815 %)
Approved, Investigational
27476412
DrugRepV_0781Pyrimethamine
Antiparasitic products, Insectisides and Repellents
Toxoplasmosis | Acute malaria
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (83.105 %)
Approved, Investigational, Vet approved
27476412
DrugRepV_0801Mebendazole
Antiparasitic products, Insectisides and Repellents
Helminthiasis (Enterobius vermicularis (pinworm), Trichuris trichiura (whipworm), Ascaris lumbricoides (common roundworm), Ancylostoma duodenale (common hookworm), Necator americanus (American hookworm) in single or mixed infections)
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (71.81 %)
Approved, Vet approved
27476412
DrugRepV_0814Albendazole
Antiparasitic products, Insectisides and Repellents
Parasitic infections
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (68.09 %)
Approved
27476412
DrugRepV_0827Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (65.085 %)
Approved, Investigational, Vet approved
27476412
DrugRepV_0836Primaquine Phosphate
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (61.24 %)
Approved
27476412
DrugRepV_0838Pentamidine Isethionate
Antiparasitic products, Insectisides and Repellents
Pneumonia
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (60.63 %)
Approved, Investigational
27476412
DrugRepV_0969Praziquantel
Antiparasitic products, Insectisides and Repellents
Schistosomiasis
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (54.16 %)
Approved, Investigational, Vet approved
27476412
DrugRepV_0970Atovaquone
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (53.93 %)
Approved
27476412
DrugRepV_1040Chloroquine Diphosphate
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (59.115 %)
Approved
27476412
DrugRepV_1188Lindane
Antiparasitic products, Insectisides and Repellents
Scabies
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (46.465 %)
Approved, Withdrawn
27476412
DrugRepV_1215Metronidazole
Antiparasitic products, Insectisides and Repellents
Amebiasis | Vaginitis | Trichomonas infections | Giardiasis | Anaerobic bacteria | Treponemal infections
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (48.465 %)
Approved
27476412
DrugRepV_1241Malathion
Antiparasitic products, Insectisides and Repellents
Pediculus humanus capitis of the scalp hair
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (49.575 %)
Approved, Investigational
27476412
DrugRepV_1320Hydroxychloroquine Sulfate
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (43.595 %)
Approved
27476412
DrugRepV_1368Quinine Hydrochloride Hydrate
Antiparasitic products, Insectisides and Repellents
Malaria | Leg cramps
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (47.065 %)
Approved
27476412
DrugRepV_1406Permethrin
Antiparasitic products, Insectisides and Repellents
Scabies
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (42.93 %)
Approved, Investigational
27476412
DrugRepV_1409Artemether
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (42.96 %)
Approved
27476412
DrugRepV_1535Ivermectin
Antiparasitic products, Insectisides and Repellents
Intestinal strongyloidiasis | Onchocerciasis
Zika virus
MEX_I_7
NA
Flow cytometry
Decrease (50 %)
Approved, Investigational, Vet approved
27476412
DrugRepV_1536Mefloquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
MEX_I_7
NA
Flow cytometry
Decrease (50 %)
Approved, Investigational
27476412
DrugRepV_1544Ivermectin
Antiparasitic products, Insectisides and Repellents
Intestinal strongyloidiasis | Onchocerciasis
Zika virus
MEX_I_7
NA
Flow cytometry
No significant effect (50 %)
Approved, Investigational, Vet approved
27476412
DrugRepV_1546Mefloquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
MEX_I_7
NA
Flow cytometry
Increase (200 %)
Approved, Investigational
27476412
DrugRepV_1549Ivermectin
Antiparasitic products, Insectisides and Repellents
Intestinal strongyloidiasis | Onchocerciasis
Zika virus
DAK_41525
NA
Flow cytometry
Decrease (60 %)
Approved, Investigational, Vet approved
27476412
DrugRepV_1551Mefloquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
DAK_41525
NA
Flow cytometry
Increase (120 %)
Approved, Investigational
27476412
DrugRepV_1554Ivermectin
Antiparasitic products, Insectisides and Repellents
Intestinal strongyloidiasis | Onchocerciasis
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (50 %)
Approved, Investigational, Vet approved
27476412
DrugRepV_1555Pyrimethamine
Antiparasitic products, Insectisides and Repellents
Toxoplasmosis | Acute malaria
Zika virus
MEX_I_7
NA
Fluorescence-based assay
No significant effect
Approved, Investigational, Vet approved
27476412
DrugRepV_1560Mefloquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (50 %)
Approved, Investigational
27476412
DrugRepV_1572Fenbendazole
Antiparasitic products, Insectisides and Repellents
Helminthiasis
Rift Valley fever virus
MP12-Luc
NA
Luciferase reporter assay
Decrease (81 %)
Vet approved
26217313
DrugRepV_1573Ivermectin
Antiparasitic products, Insectisides and Repellents
Intestinal strongyloidiasis | Onchocerciasis
Rift Valley fever virus
MP12-Luc
NA
Luciferase reporter assay
Decrease (57 %)
Approved, Investigational, Vet approved
26217313
DrugRepV_1616Pyronaridine tetraphosphate
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
Recombinant, infectious Ebola virus encoding green fluorescent protein
NA
Cell based assay
Decrease (50 %)
Approved
26834994
DrugRepV_1618Chloroquine Diphosphate
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
Recombinant, infectious Ebola virus encoding green fluorescent protein
NA
Cell based assay
Decrease (50 %)
Approved
26834994
DrugRepV_1653Tenonitrozole
Antiparasitic products, Insectisides and Repellents
Protozoal infections
Zika virus
MR766
NA
Cell viability assay
No significant effect (0 %)
Experimental
27571349
DrugRepV_1655Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Zika virus
MR766
NA
Cell viability assay
Decrease (53.6 %)
Approved, Investigational, Vet approved
27571349
DrugRepV_1694Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Zika virus
MR766
NA
Cell viability assay
Decrease (51.2 %)
Approved
27571349
DrugRepV_1724Tenonitrozole
Antiparasitic products, Insectisides and Repellents
Protozoal infections
Zika virus
MR766
NA
Cell viability assay
No significant effect (0 %)
Experimental
27571349
DrugRepV_1726Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Zika virus
MR766
NA
Cell viability assay
Decrease (62.1 %)
Approved, Investigational, Vet approved
27571349
DrugRepV_1765Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Zika virus
MR766
NA
Cell viability assay
Decrease (97.3 %)
Approved
27571349
DrugRepV_1795Tenonitrozole
Antiparasitic products, Insectisides and Repellents
Protozoal infections
Zika virus
MR766
NA
Cell viability assay
No significant effect
Experimental
27571349
DrugRepV_1797Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Zika virus
MR766
NA
Cell viability assay
No significant effect
Approved, Investigational, Vet approved
27571349
DrugRepV_1836Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Zika virus
MR766
NA
Cell viability assay
No significant effect
Approved
27571349
DrugRepV_1868Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Zika virus
NA
NA
Cell viability assay
Decrease (50 %)
Approved
27571349
DrugRepV_1869Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Zika virus
NA
NA
Cell viability assay
Decrease (50 %)
Approved
27571349
DrugRepV_1878Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Zika virus
PRVABC-59 (2015 Puerto Rican strain)
NA
Western blot
Decrease (Decrease Band intensity)
Approved
27571349
DrugRepV_1879Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Zika virus
PRVABC-59 (2015 Puerto Rican strain)
NA
Western blot
Decrease (Decrease Band intensity)
Approved
27571349
DrugRepV_1881Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Zika virus
PRVABC-59 (2015 Puerto Rican strain)
NA
Enzyme-linked immunosorbent assay
Decrease
Approved
27571349
DrugRepV_1883Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Zika virus
PRVABC-59 (2015 Puerto Rican strain)
NA
Plaque assay
Decrease (50 %)
Approved
27571349
DrugRepV_1884Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Zika virus
FSS13025
NA
Real-time PCR
Decrease (50 %)
Approved
27571349
DrugRepV_1886Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Zika virus
FSS13025
NA
Real-time PCR
Decrease
Approved
27571349
DrugRepV_1888Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Zika virus
PRVABC-59 (2015 Puerto Rican strain)
NA
Western blot
Decrease (Decrease Band intensity)
Approved
27571349
DrugRepV_1889Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Zika virus
PRVABC-59 (2015 Puerto Rican strain)
NA
Western blot
Decrease (Decrease Band intensity)
Approved
27571349
DrugRepV_1910Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
PLCal_ZV
NA
MTT assay
Decrease (50 %)
Approved
29315671
DrugRepV_1911Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
PLCal_ZV
NA
MTT assay
Decrease (50 %)
Approved
29315671
DrugRepV_1913Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
PLCal_ZV
NA
Plaque assay
Decrease (50 %)
Approved
29315671
DrugRepV_1914Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
PLCal_ZV
NA
Plaque assay
Decrease (50 %)
Approved
29315671
DrugRepV_1916Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
PLCal_ZV
NA
Time of addition assay
Decrease (50 %)
Approved
29315671
DrugRepV_1917Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
PLCal_ZV
NA
Time of addition assay
Decrease (62.5 %)
Approved
29315671
DrugRepV_1919Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
PLCal_ZV
NA
Real-time PCR
Decrease (85.7 %)
Approved
29315671
DrugRepV_1920Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
PLCal_ZV
NA
Real-time PCR
Decrease (99 %)
Approved
29315671
DrugRepV_1922Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
PLCal_ZV
NA
MTT assay
Decrease (65 %)
Approved
29315671
DrugRepV_1923Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
PLCal_ZV
NA
MTT assay
Decrease (70 %)
Approved
29315671
DrugRepV_1941Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Zika virus
SZ-WIV01
NA
Plaque assay
Decrease (>100 Fold)
Approved, Investigational, Vet approved
28480282
DrugRepV_1942Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Zika virus
SZ-WIV01
NA
Immunoflourescence assay
Decrease (100 %)
Approved, Investigational, Vet approved
28480282
DrugRepV_1943Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Zika virus
SZ-WIV01
NA
Western blot
Decrease (100 Band Intensity)
Approved, Investigational, Vet approved
28480282
DrugRepV_1944Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Zika virus
SZ-WIV01
NA
Real-time PCR
Decrease (98 %)
Approved, Investigational, Vet approved
28480282
DrugRepV_1945Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Zika virus
SZ-WIV01
NA
Real-time PCR
Decrease
Approved, Investigational, Vet approved
28480282
DrugRepV_1946Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Zika virus
SZ-WIV01
NA
Real-time PCR
Decrease (100 %)
Approved, Investigational, Vet approved
28480282
DrugRepV_1947Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Zika virus
SZ-WIV01
NA
Real-time PCR
Decrease
Approved, Investigational, Vet approved
28480282
DrugRepV_1948Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Zika virus
SZ-WIV01
NA
Real-time PCR
Decrease (100 %)
Approved, Investigational, Vet approved
28480282
DrugRepV_1949Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Zika virus
SZ-WIV01
NA
Real-time PCR
Decrease (100 %)
Approved, Investigational, Vet approved
28480282
DrugRepV_1950Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Zika virus
SZ-WIV01
NA
Real-time PCR
Decrease (98 %)
Approved, Investigational, Vet approved
28480282
DrugRepV_1951Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Zika virus
SZ-WIV01
NA
Real-time PCR
Decrease (100 %)
Approved, Investigational, Vet approved
28480282
DrugRepV_1952Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Zika virus
SZ-WIV01
NA
Plaque assay
Decrease (100 %)
Approved, Investigational, Vet approved
28480282
DrugRepV_1953Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Zika virus
SZ-WIV01
NA
Immunoflourescence assay
Decrease (100 %)
Approved, Investigational, Vet approved
28480282
DrugRepV_1954Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Zika virus
SZ-WIV01
NA
Western blot
Decrease (100 Band Intensity)
Approved, Investigational, Vet approved
28480282
DrugRepV_1955Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Zika virus
SZ-WIV01
NA
Real-time PCR
Decrease (98 %)
Approved, Investigational, Vet approved
28480282
DrugRepV_1956Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Zika virus
SZ-WIV01
NA
Real-time PCR
Decrease
Approved, Investigational, Vet approved
28480282
DrugRepV_1957Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Zika virus
SZ-WIV01
NA
Real-time PCR
Decrease
Approved, Investigational, Vet approved
28480282
DrugRepV_1958Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Zika virus
SZ-WIV01
NA
Real-time PCR
Decrease
Approved, Investigational, Vet approved
28480282
DrugRepV_1959Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Zika virus
SZ-WIV01
NA
Real-time PCR
Decrease
Approved, Investigational, Vet approved
28480282
DrugRepV_1960Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Zika virus
SZ-WIV01
NA
Real-time PCR
Decrease (100 %)
Approved, Investigational, Vet approved
28480282
DrugRepV_1961Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Zika virus
SZ-WIV01
NA
Real-time PCR
Decrease (100 %)
Approved, Investigational, Vet approved
28480282
DrugRepV_1962Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Zika virus
SZ-WIV01
NA
Real-time PCR
Decrease (98 %)
Approved, Investigational, Vet approved
28480282
DrugRepV_1963Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Zika virus
SZ-WIV01
NA
Real-time PCR
Decrease (100 %)
Approved, Investigational, Vet approved
28480282
DrugRepV_1967Emetine Dihydrochloride Hydrate
Antiparasitic products, Insectisides and Repellents
Protozoal disease
Middle East respiratory syndrome coronavirus
Jordan
NA
Enzyme-linked immunosorbent assay
Decrease (50 %)
NA
24841273
DrugRepV_1968Chloroquine Diphosphate
Antiparasitic products, Insectisides and Repellents
Parasitic infections
Middle East respiratory syndrome coronavirus
Jordan
NA
Enzyme-linked immunosorbent assay
Decrease (50 %)
Approved
24841273
DrugRepV_1969Hydroxychloroquine Sulfate
Antiparasitic products, Insectisides and Repellents
Malaria
Middle East respiratory syndrome coronavirus
Jordan
NA
Enzyme-linked immunosorbent assay
Decrease (50 %)
Approved
24841273
DrugRepV_1970Mefloquine
Antiparasitic products, Insectisides and Repellents
Malaria
Middle East respiratory syndrome coronavirus
Jordan
NA
Enzyme-linked immunosorbent assay
Decrease (50 %)
Approved, Investigational
24841273
DrugRepV_1971Amodiaquine Dihydrochloride Dihydrate
Antiparasitic products, Insectisides and Repellents
Malaria
Middle East respiratory syndrome coronavirus
Jordan
NA
Enzyme-linked immunosorbent assay
Decrease (50 %)
Approved, Investigational
24841273
DrugRepV_1992Emetine Dihydrochloride Hydrate
Antiparasitic products, Insectisides and Repellents
Protozoal disease
Middle East respiratory syndrome coronavirus
NA
NA
Cytopathic effect (CPE) assay
Decrease (50 %)
NA
24841273
DrugRepV_1993Chloroquine Diphosphate
Antiparasitic products, Insectisides and Repellents
Parasitic infections
Severe acute respiratory syndrome coronavirus
NA
NA
Cytopathic effect (CPE) assay
Decrease (50 %)
Approved
24841273
DrugRepV_1994Hydroxychloroquine Sulfate
Antiparasitic products, Insectisides and Repellents
Malaria
Severe acute respiratory syndrome coronavirus
NA
NA
Cytopathic effect (CPE) assay
Decrease (50 %)
Approved
24841273
DrugRepV_1995Mefloquine
Antiparasitic products, Insectisides and Repellents
Malaria
Severe acute respiratory syndrome coronavirus
NA
NA
Cytopathic effect (CPE) assay
Decrease (50 %)
Approved, Investigational
24841273
DrugRepV_1996Amodiaquine Dihydrochloride dihydrate
Antiparasitic products, Insectisides and Repellents
Malaria
Severe acute respiratory syndrome coronavirus
NA
NA
Cytopathic effect (CPE) assay
Decrease (50 %)
Approved, Investigational
24841273
DrugRepV_2026Artemisinin
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
Zaire strain-pEBOV
NA
Firefly luciferase assay
Decrease (50 %)
Experimental
26585243
DrugRepV_2035Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Middle East respiratory syndrome coronavirus
EMC/2012
NA
Cell viability assay
Decrease (50 %)
Approved
24841269
DrugRepV_2039Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Severe acute respiratory syndrome coronavirus
NA
NA
Cell viability assay
Decrease (50 %)
Approved
24841269
DrugRepV_2043Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Severe acute respiratory syndrome coronavirus
229E-GFP
NA
Cell viability assay
Decrease (50 %)
Approved
24841269
DrugRepV_2051Pyrimethamine
Antiparasitic products, Insectisides and Repellents
Toxoplasmosis | Acute malaria
Middle East respiratory syndrome coronavirus
EMC/2012
NA
Cell viability assay
No significant decrease (20 %)
Approved, Investigational, Vet approved
24841269
DrugRepV_2054Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Chikungunya virus
S27
NA
Real-time PCR
Decrease (50 %)
Approved
27742486
DrugRepV_2055Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Chikungunya virus
S27
NA
Real-time PCR
Decrease (50 %)
Approved, Investigational, Vet approved
27742486
DrugRepV_2056Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Chikungunya virus
S27
NA
Immunoflourescence assay
Decrease
Approved
27742486
DrugRepV_2057Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Chikungunya virus
S27
NA
Immunoflourescence assay
Decrease
Approved, Investigational, Vet approved
27742486
DrugRepV_2058Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Chikungunya virus
0611aTw
NA
Real-time PCR
Decrease (50 %)
Approved
27742486
DrugRepV_2059Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Chikungunya virus
0611aTw
NA
Real-time PCR
Decrease (50 %)
Approved, Investigational, Vet approved
27742486
DrugRepV_2060Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Chikungunya virus
081bTw
NA
Real-time PCR
Decrease (50 %)
Approved
27742486
DrugRepV_2061Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Chikungunya virus
081bTw
NA
Real-time PCR
Decrease (50 %)
Approved, Investigational, Vet approved
27742486
DrugRepV_2062Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Chikungunya virus
S27
NA
Real-time PCR
Decrease (50 %)
Approved
27742486
DrugRepV_2063Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Chikungunya virus
S27
NA
Real-time PCR
Decrease (50 %)
Approved, Investigational, Vet approved
27742486
DrugRepV_2066Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Severe acute respiratory syndrome coronavirus
NA
NA
Immunoblot assay
Decrease
Approved
15215127
DrugRepV_2067Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Severe acute respiratory syndrome coronavirus
NA
NA
Immunoflourescence assay
Decrease
Approved
15215127
DrugRepV_2068Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Severe acute respiratory syndrome coronavirus
NA
NA
Real-time PCR
Decrease
Approved
15215127
DrugRepV_2156Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
Decrease (96.1181392 %)
Approved, Investigational, Vet approved
27742486
DrugRepV_2161Atovaquone
Antiparasitic products, Insectisides and Repellents
Malaria
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
Decrease (55.760271 %)
Approved
27742486
DrugRepV_2187Ivermectin
Antiparasitic products, Insectisides and Repellents
Intestinal strongyloidiasis | Onchocerciasis
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
No significant decrease (12.5546344 %)
Approved, Investigational, Vet approved
27742486
DrugRepV_2249Praziquantel
Antiparasitic products, Insectisides and Repellents
Schistosomiasis
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
No significant decrease (5.93918289 %)
Approved, Investigational, Vet approved
27742486
DrugRepV_2257Pyrimethamine
Antiparasitic products, Insectisides and Repellents
Toxoplasmosis | Acute malaria
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
No significant decrease (5.73171647 %)
Approved, Investigational, Vet approved
27742486
DrugRepV_2304Levamisole Hydrochloride
Antiparasitic products, Insectisides and Repellents
Helminthiasis
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
No significant decrease (4.33501607 %)
Approved, Investigational, Vet approved, Withdrawn
27742486
DrugRepV_2416Artemisinin
Antiparasitic products, Insectisides and Repellents
Malaria
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
No significant decrease (1.94527744 %)
Experimental
27742486
DrugRepV_2502Meglumine
Antiparasitic products, Insectisides and Repellents
NA
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
No significant decrease (0.08526202 %)
Approved
27742486
DrugRepV_2508Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
Decrease (100 %)
Approved
27742486
DrugRepV_2528Artemether
Antiparasitic products, Insectisides and Repellents
Malaria
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
Increase (-0.4769483 %)
Approved
27742486
DrugRepV_2550Albendazole
Antiparasitic products, Insectisides and Repellents
Parasitic infections
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
Increase (-0.8595872 %)
Approved
27742486
DrugRepV_2555Flubendazole
Antiparasitic products, Insectisides and Repellents
Helminthiasis
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
Increase (-0.9381124 %)
Experimental, Withdrawn
27742486
DrugRepV_2580Quinine Hydrochloride dihydrate
Antiparasitic products, Insectisides and Repellents
Malaria | Leg cramps
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
Increase (-1.3590955 %)
Approved
27742486
DrugRepV_2702Metronidazole
Antiparasitic products, Insectisides and Repellents
Amebiasis | Vaginitis | Trichomonas infections | Giardiasis | Anaerobic bacteria | Treponemal infections
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
Increase (-2.9895213 %)
Approved
27742486
DrugRepV_2738Fenbendazole
Antiparasitic products, Insectisides and Repellents
Helminthiasis
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
Increase (-3.5894807 %)
Vet approved
27742486
DrugRepV_2832Ornidazole
Antiparasitic products, Insectisides and Repellents
Elective Colorectal Surgery
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
Increase (-5.9457143 %)
Investigational
27742486
DrugRepV_2936Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Chikungunya virus
DRDE-06
NA
Neutral red uptake assay
Decrease (50 %)
Approved
20336760
DrugRepV_2937Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Chikungunya virus
DRDE-06
NA
Neutral red uptake assay
Decrease (50 %)
Approved
20336760
DrugRepV_2938Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Chikungunya virus
DRDE-06
NA
Neutral red uptake assay
Decrease (50 %)
Approved
20336760
DrugRepV_2939Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Chikungunya virus
DRDE-06
NA
Neutral red uptake assay
Decrease (90 %)
Approved
20336760
DrugRepV_2940Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Chikungunya virus
DRDE-06
NA
Neutral red uptake assay
Decrease (90 %)
Approved
20336760
DrugRepV_2941Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Chikungunya virus
DRDE-06
NA
Neutral red uptake assay
Decrease (90 %)
Approved
20336760
DrugRepV_2942Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Chikungunya virus
DRDE-06
NA
Plaque assay
Decrease (3 logs)
Approved
20336760
DrugRepV_2943Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Chikungunya virus
DRDE-06
NA
Plaque assay
Decrease (3 logs)
Approved
20336760
DrugRepV_2944Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Chikungunya virus
DRDE-06
NA
Plaque assay
Decrease (3 logs)
Approved
20336760
DrugRepV_2945Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Chikungunya virus
DRDE-06
NA
Plaque assay
Decrease (94 %)
Approved
20336760
DrugRepV_2946Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Chikungunya virus
DRDE-06
NA
Plaque assay
Decrease (65 %)
Approved
20336760
DrugRepV_2947Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Chikungunya virus
DRDE-06
NA
Plaque assay
Decrease (70 %)
Approved
20336760
DrugRepV_2948Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Chikungunya virus
DRDE-06
NA
Real-time PCR
Decrease
Approved
20336760
DrugRepV_2949Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Chikungunya virus
DRDE-06
NA
Real-time PCR
Decrease
Approved
20336760
DrugRepV_2950Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Chikungunya virus
DRDE-06
NA
Real-time PCR
Decrease
Approved
20336760
DrugRepV_2951Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Chikungunya virus
DRDE-06
NA
Immunoflourescence assay
Decrease
Approved
20336760
DrugRepV_3040Ivermectin
Antiparasitic products, Insectisides and Repellents
Intestinal strongyloidiasis | Onchocerciasis
Chikungunya virus
LR2006 OPY1
NA
Luciferase reporter assay
Decrease (50 %)
Approved, Investigational, Vet approved
26752081
DrugRepV_3045Ivermectin
Antiparasitic products, Insectisides and Repellents
Intestinal strongyloidiasis | Onchocerciasis
Chikungunya virus
LR2006 OPY1
NA
Luciferase reporter assay
Decrease (50 %)
Approved, Investigational, Vet approved
26752081
DrugRepV_3049Ivermectin
Antiparasitic products, Insectisides and Repellents
Intestinal strongyloidiasis | Onchocerciasis
Chikungunya virus
CHIKV-Rluc
NA
Luciferase reporter assay
Decrease (100 %)
Approved, Investigational, Vet approved
26752081
DrugRepV_3058Atovaquone
Antiparasitic products, Insectisides and Repellents
Malaria
Chikungunya virus
CHIKV-Rluc
NA
Luciferase reporter assay
Decrease (20 %)
Approved
26752081
DrugRepV_3059Triclabendazole
Antiparasitic products, Insectisides and Repellents
Fascioliasis (Parasitic infection)
Chikungunya virus
CHIKV-Rluc
NA
Luciferase reporter assay
Decrease (20 %)
Approved, Investigational
26752081
DrugRepV_3067Ivermectin
Antiparasitic products, Insectisides and Repellents
Intestinal strongyloidiasis | Onchocerciasis
Chikungunya virus
CHIKV-Rluc
NA
Northern blot
Decrease
Approved, Investigational, Vet approved
26752081
DrugRepV_3070Ivermectin
Antiparasitic products, Insectisides and Repellents
Intestinal strongyloidiasis | Onchocerciasis
Chikungunya virus
CHIKV-Rluc
NA
Western blot
Decrease
Approved, Investigational, Vet approved
26752081
DrugRepV_3071Ivermectin
Antiparasitic products, Insectisides and Repellents
Intestinal strongyloidiasis | Onchocerciasis
Chikungunya virus
CHIKV-Rluc
NA
Western blot
Decrease
Approved, Investigational, Vet approved
26752081
DrugRepV_3074Ivermectin
Antiparasitic products, Insectisides and Repellents
Intestinal strongyloidiasis | Onchocerciasis
Chikungunya virus
CHIKV-Rluc
NA
Western blot
Decrease
Approved, Investigational, Vet approved
26752081
DrugRepV_3075Ivermectin
Antiparasitic products, Insectisides and Repellents
Intestinal strongyloidiasis | Onchocerciasis
Chikungunya virus
CHIKV-Rluc
NA
Western blot
Decrease
Approved, Investigational, Vet approved
26752081
DrugRepV_3081Ivermectin
Antiparasitic products, Insectisides and Repellents
Intestinal strongyloidiasis | Onchocerciasis
Chikungunya virus
CHIKV-Rluc
NA
Plaque assay
Decrease (3.5 Log)
Approved, Investigational, Vet approved
26752081
DrugRepV_3084Ivermectin
Antiparasitic products, Insectisides and Repellents
Intestinal strongyloidiasis | Onchocerciasis
Chikungunya virus
NA
NA
Plaque assay
Decrease (3 Log)
Approved, Investigational, Vet approved
26752081
DrugRepV_3087Ivermectin
Antiparasitic products, Insectisides and Repellents
Intestinal strongyloidiasis | Onchocerciasis
Chikungunya virus
NA
NA
Plaque assay
Decrease (0.2 Log)
Approved, Investigational, Vet approved
26752081
DrugRepV_3102Emetine Dihydrochloride
Antiparasitic products, Insectisides and Repellents
Protozoal disease
Chikungunya virus
CHIKV-0708
NA
Immunoflourescence assay
Decrease (99.5 %)
NA
23275491
DrugRepV_3317Tizoxanide
Antiparasitic products, Insectisides and Repellents
Cryptosporidiosis and Giardiasis
Influenza virus
B/Brisbane/46/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_3318Tizoxanide
Antiparasitic products, Insectisides and Repellents
Cryptosporidiosis and Giardiasis
Influenza virus
B/Sydney/39/2014
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_3319Tizoxanide
Antiparasitic products, Insectisides and Repellents
Cryptosporidiosis and Giardiasis
Influenza virus
A/Perth/265/2009
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_3320Tizoxanide
Antiparasitic products, Insectisides and Repellents
Cryptosporidiosis and Giardiasis
Influenza virus
A/Osaka/180/2009
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_3321Tizoxanide
Antiparasitic products, Insectisides and Repellents
Cryptosporidiosis and Giardiasis
Influenza virus
A/New Caledonia/104/2014
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_3322Tizoxanide
Antiparasitic products, Insectisides and Repellents
Cryptosporidiosis and Giardiasis
Influenza virus
A/Newcastle/22/2014
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_3372Pyrimethamine
Antiparasitic products, Insectisides and Repellents
Toxoplasmosis | Acute malaria
Influenza virus
A/ WSN/1933 (H1N1)
Pathway
High-throughput screening
Decrease (50 %)
Approved, Investigational, Vet approved
24096239
DrugRepV_3373Emetine
Antiparasitic products, Insectisides and Repellents
Protozoal disease
Influenza virus
A/ WSN/1933 (H1N1)
Pathway
High-throughput screening
Decrease (50 %)
Experimental
24096239
DrugRepV_3515Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A/Ohio/88/2012
Pathway
Virus yield reduction assay
Decrease (90 %)
Approved, Investigational, Vet approved
24449767
DrugRepV_3516Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A/Ohio/83/2012
Pathway
Virus yield reduction assay
Decrease (90 %)
Approved, Investigational, Vet approved
24449767
DrugRepV_3517Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A/Washington/01/2007
Pathway
Virus yield reduction assay
Decrease (90 %)
Approved, Investigational, Vet approved
24449767
DrugRepV_3518Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A/Texas/12/2007
Pathway
Virus yield reduction assay
Decrease (90 %)
Approved, Investigational, Vet approved
24449767
DrugRepV_3519Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A/California/04/2009
Pathway
Virus yield reduction assay
Decrease (90 %)
Approved, Investigational, Vet approved
24449767
DrugRepV_3588Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
EBOV trVLP
NA
Luciferase reporter assay
Decrease (50 %)
Approved
30149038
DrugRepV_3709Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
NA
NA
NA
Decrease (99.9 %)
Approved
24713118
DrugRepV_4031Praziquantel
Antiparasitic products, Insectisides and Repellents
Schistosomiasis
Hendra virus
NA
NA
Immunolabeling assay
Decrease (50 %)
Approved, Investigational, Vet approved
20668647
DrugRepV_4046Praziquantel
Antiparasitic products, Insectisides and Repellents
Schistosomiasis
Nipah virus
NA
NA
Immunolabeling assay
Decrease (50 %)
Approved, Investigational, Vet approved
20668647
DrugRepV_4092Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
Mayinga
NA
Inhibition assay
Decrease (50 %)
Approved
26069727
DrugRepV_4093Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
Bundibugyo
NA
Inhibition assay
Decrease (50 %)
Approved
26069727
DrugRepV_4095Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Influenza virus
A/turkey/ England/50-92/91
Pathway
Inhibition assay
Decrease (50 %)
Approved
26069727
DrugRepV_4219Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Chikungunya virus
NA
NA
Cytopathic effect (CPE) assay
Decrease (50 %)
Approved
25970561
DrugRepV_4295Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
Approved
29499487
DrugRepV_4296Piperazine
Antiparasitic products, Insectisides and Repellents
Parasitic infections (Ascariasis)
Chikungunya virus
DRDE-07
NA
Immunoflourescence assay
Decrease
Approved, Vet approved
28842264
DrugRepV_4297Piperazine
Antiparasitic products, Insectisides and Repellents
Parasitic infections (Ascariasis)
Chikungunya virus
DRDE-07
NA
Plaque reduction assay
Decrease (81 %)
Approved, Vet approved
28842264
DrugRepV_4712Mefloquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
MR766
NA
Plaque assay
Decrease (50 %)
Approved, Investigational
27889529
DrugRepV_4716Amodiaquine Dihydrochloride
Antiparasitic products, Insectisides and Repellents
Malaria
Middle East respiratory syndrome coronavirus
EMC/2012 strain
NA
Cytopathic effect (CPE) assay
Decrease (50 %)
NA
29795047
DrugRepV_4717Amodiaquine Dihydrochloride Dihydrate
Antiparasitic products, Insectisides and Repellents
Malaria
Middle East respiratory syndrome coronavirus
EMC/2012 strain
NA
Cytopathic effect (CPE) assay
Decrease (50 %)
Approved, Investigational
29795047
DrugRepV_4718Chloroquine Diphosphate
Antiparasitic products, Insectisides and Repellents
Parasitic infections
Middle East respiratory syndrome coronavirus
EMC/2012 strain
NA
Cytopathic effect (CPE) assay
Decrease (50 %)
Approved, Investigational, Vet approved
29795047
DrugRepV_4719Hydroxychloroquine Sulfate
Antiparasitic products, Insectisides and Repellents
Malaria
Middle East respiratory syndrome coronavirus
EMC/2012 strain
NA
Cytopathic effect (CPE) assay
Decrease (50 %)
Approved
29795047
DrugRepV_4727Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Middle East respiratory syndrome coronavirus
Jordan
NA
Immunoflourescence assay
No significant effect
Approved
29566060
DrugRepV_5083Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Crimean-Congo hemorrhagic fever virus
86-07
NA
Plaque assay
Decrease (50 %)
Approved
25796972
DrugRepV_5084Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Crimean-Congo hemorrhagic fever virus
86-07
NA
Plaque assay
Decrease (50 %)
Approved
25796972
DrugRepV_5087Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Crimean-Congo hemorrhagic fever virus
87-07
NA
Plaque assay
Decrease (50 %)
Approved
25796972
DrugRepV_5177Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Rift Valley fever virus
MP12
NA
Fluorescence-based assay
Decrease (1 log Resazurin fluorescence)
Investigational
25267680
DrugRepV_5178Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Rift Valley fever virus
MP12
NA
Plaque assay
Decrease
Investigational
25267680
DrugRepV_5179Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Rift Valley fever virus
MP12
NA
Plaque assay
Decrease (50 %)
Investigational
25267680
DrugRepV_5212Suramin Sodium
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Rift Valley fever virus
NA
NA
RVFV nucleocapsid (N) protein RNA-binding activity
Decrease (50 %)
Investigational
22644268
DrugRepV_5395Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Lassa virus
Josiah
NA
Luciferase assay
Decrease (50 %)
Approved
30700611
DrugRepV_5396Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
Mayinga
NA
Luciferase assay
Decrease (50 %)
Approved
30700611
DrugRepV_5397Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Lassa virus
Josiah
NA
Luciferase assay
Decrease (50 %)
Approved
30700611
DrugRepV_5398Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Ebola virus
Mayinga
NA
Luciferase assay
Decrease (50 %)
Approved
30700611
DrugRepV_5409Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
PLCal_ZV
NA
MTT assay
Decrease (50 %)
Approved
30801742
DrugRepV_5412Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
MR 766
NA
MTT assay
Decrease (50 %)
Approved
30801742
DrugRepV_5415Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
PRVABC59
NA
MTT assay
Decrease (50 %)
Approved
30801742
DrugRepV_5454Atovaquone
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
MR766
NA
Plaque assay
Decrease (2 log10PFU/ml)
Approved
30894466
DrugRepV_5455Atovaquone
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
MR766
NA
Plaque assay
Decrease (5.5 log10PFU/ml)
Approved
30894466
DrugRepV_5456Atovaquone
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
MR766
NA
Plaque assay
Decrease (2 log10PFU/ml)
Approved
30894466
DrugRepV_5457Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
A/Sydney/185/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5458Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
A/Singapore/TT1275/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5459Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
A/Sydney/158/2016
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5460Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
A/Victoria/2500/2016
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5461Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
A/Malaysia/2/2014
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5462Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
A/Victoria/1031/2010
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5463Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
A/Victoria/1035/2010
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5464Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
A/Victoria/92/2012
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5465Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
A/Malaysia/22/2013
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5466Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
A/Sydney/236/2014
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5467Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
B/South Australia/2/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5468Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
B/Canberra/1/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5469Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
B/South Australia/5/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5470Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
B/Perth/136/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5474Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
nCoV- 2019BetaCoV/Wuhan/WIV04/2019
NA
qRT-PCR
Decrease (50 %)
Approved
32020029
DrugRepV_5476Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
SARS Coronavirus-2
nCoV- 2019BetaCoV/Wuhan/WIV04/2019
NA
qRT-PCR
Decrease (50 %)
Approved, Investigational, Vet approved
32020029
DrugRepV_5480Ivermectin
Antiparasitic products, Insectisides and Repellents
Intestinal strongyloidiasis | Onchocerciasis
Zika virus
(Asian/Cook Islands/2014
NA
Plaque assay
Decrease (50 %)
Approved, Investigational, Vet approved
32135219
DrugRepV_5481Ivermectin
Antiparasitic products, Insectisides and Repellents
Intestinal strongyloidiasis | Onchocerciasis
Zika virus
(Asian/Cook Islands/2014
NA
RT-qPCR
Decrease (50 %)
Approved, Investigational, Vet approved
32135219
DrugRepV_5490Primaquine Diphosphate
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
PRVABC59
NA
Cell viability assay
Decrease (50 %)
Approved
31669333
DrugRepV_5491Amodiaquine Dihydrochloride Dihydrate
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
NA
NA
Cell based assay
Decrease (50 %)
Approved, Investigational
31882748
DrugRepV_5492Amodiaquine Dihydrochloride Dihydrate
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
NA
NA
Cell based assay
Decrease (50 %)
Approved, Investigational
31882748
DrugRepV_5493Amodiaquine Dihydrochloride Dihydrate
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
NA
NA
Cell based assay
Decrease (50 %)
Approved, Investigational
31882748
DrugRepV_5494Artesunate
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
NA
NA
Cell based assay
Decrease (50 %)
Approved, Investigational
31882748
DrugRepV_5505Mefloquine hydrochloride
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
GX_P2V/pangolin/2017/Guangxi
NA
qRT-PCR
Decrease
Approved, Investigational
32149769
DrugRepV_5574Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
2019-nCoV/USA-WA1/2020
NA
NA
Decrease (50 %)
Approved
32353859
DrugRepV_5773Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Dengue virus
Singapore isolates
Pathway
Plaque assay
Decrease (82 %)
Approved
25251726
DrugRepV_5806Ivermectin
Antiparasitic products, Insectisides and Repellents
Intestinal strongyloidiasis | Onchocerciasis
Dengue virus
NA
Pathway
Immunoflourescence assay
Decrease (84.62 %)
Approved, Investigational, Vet approved
22155902
DrugRepV_5881Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (78 %)
Approved
24680954
DrugRepV_5882Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (58 %)
Approved
24680954
DrugRepV_5883Chloroquine ethyl phenyl Mustard
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (> 99 %)
NA
24680954
DrugRepV_5884Chloroquine Mustard
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (> 99 %)
NA
24680954
DrugRepV_5885Chloroquine Pamoate
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
24680954
DrugRepV_5886Chloroquine Sulfate
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (30 %)
NA
24680954
DrugRepV_5888Primaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
No significant effect (0 %)
Approved
24680954
DrugRepV_5889Quinine Hydrobromide Hydrate
Antiparasitic products, Insectisides and Repellents
Malaria | Leg cramps
Dengue virus
NA
Pathway
Plaque assay
Decrease (38 %)
NA
24680954
DrugRepV_5891Amodiaquine derivative (AQD1)
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (90 %)
NA
24680954
DrugRepV_5892Amodiaquine derivative (AQD2)
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (70 %)
NA
24680954
DrugRepV_5893Amodiaquine derivative (AQD3)
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (100 %)
NA
24680954
DrugRepV_5894Amodiaquine derivative (AQD4)
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (100 %)
NA
24680954
DrugRepV_5895Amodiaquine derivative (AQD5)
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (20 %)
NA
24680954
DrugRepV_5896Amodiaquine derivative (AQD6)
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (100 %)
NA
24680954
DrugRepV_5897Amodiaquine derivative (AQD7)
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (97 %)
NA
24680954
DrugRepV_5898Amodiaquine derivative (AQD8)
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
No significant effect (0 %)
NA
24680954
DrugRepV_5899Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (50 %)
Approved
24680954
DrugRepV_5900Amodiaquine derivative (AQD1)
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
24680954
DrugRepV_5901Amodiaquine derivative (AQD2)
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
24680954
DrugRepV_5902Amodiaquine derivative (AQD3)
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
24680954
DrugRepV_5903Amodiaquine derivative (AQD4)
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
24680954
DrugRepV_5904Amodiaquine derivative (AQD5)
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
24680954
DrugRepV_5905Amodiaquine derivative (AQD6)
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
24680954
DrugRepV_5906Amodiaquine derivative (AQD7)
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
24680954
DrugRepV_5907Amodiaquine derivative (AQD8)
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
24680954
DrugRepV_5909Chloroquine Mustard
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
24680954
DrugRepV_5910Chloroquine ethyl phenyl Mustard
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
24680954
DrugRepV_5911Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (50 %)
Approved
24680954
DrugRepV_5912Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (50 %)
Approved
24680954
DrugRepV_5913Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (50 %)
Approved
24680954
DrugRepV_5914Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Real-time PCR
Decrease (90 %)
Approved
24680954
DrugRepV_5915Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Real-time PCR
Decrease (90 %)
Approved
24680954
DrugRepV_5916Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (98 %)
Approved
24680954
DrugRepV_5917Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (90 %)
Approved
24680954
DrugRepV_5918Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (90 %)
Approved
24680954
DrugRepV_5919Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (100 %)
Approved
24680954
DrugRepV_5920Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (80 %)
Approved
24680954
DrugRepV_5921Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (100 %)
Approved
24680954
DrugRepV_5922Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
No significant effect
Approved
24680954
DrugRepV_5923Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (2 Fold)
Approved
24680954
DrugRepV_5924Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (3 Fold)
Approved
24680954
DrugRepV_5925Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (90 %)
Approved
24680954
DrugRepV_5926Amodiaquine derivative (AQD8)
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (90 %)
NA
24680954
DrugRepV_5927Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (90 %)
Approved
24680954
DrugRepV_5928Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (90 %)
Approved
24680954
DrugRepV_5970Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
New Guinea
Pathway
Plaque assay
Decrease
Approved
24773578
DrugRepV_5971Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
New Guinea
Pathway
Real-time PCR
Decrease
Approved
24773578
DrugRepV_5972Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
New Guinea
Pathway
Immunoflourescence assay
Decrease
Approved
24773578
DrugRepV_5973Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
New Guinea
Pathway
Plaque assay
Decrease
Approved
25664975
DrugRepV_6037Quinine sulfate
Antiparasitic products, Insectisides and Repellents
Malaria | Leg cramps
Dengue virus
16681
Pathway
Focus forming assay
Decrease (81 %)
NA
30055216
DrugRepV_6122Mefloquine
Antiparasitic products, Insectisides and Repellents
Malaria
Dengue virus
NA
Pathway
Plaque assay
Decrease (50 %)
Approved, Investigational
27889529
DrugRepV_6314Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Dengue virus
NGC
Pathway
Flow cytometry
Decrease (92 %)
Investigational
16309754
DrugRepV_6319Ivermectin
Antiparasitic products, Insectisides and Repellents
Intestinal strongyloidiasis | Onchocerciasis
Dengue virus
New Guinea C
Pathway
Immunoflourescence assay
Decrease (84.62 %)
Approved, Investigational, Vet approved
22155902
DrugRepV_7059Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
Decrease (98 %)
Approved
24680954
DrugRepV_7060Primaquine
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
Decrease (20 %)
Approved
24680954
DrugRepV_7061Chloroquine ethyl phenyl Mustard
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
Decrease (> 99 %)
NA
24680954
DrugRepV_7062Chloroquine Mustard
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
Decrease (> 99 %)
NA
24680954
DrugRepV_7063Chloroquine Pamoate
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
Decrease (10 %)
NA
24680954
DrugRepV_7064Chloroquine Sulfate
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
No significant effect (0 %)
NA
24680954
DrugRepV_7066Primaquine
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
No significant effect (0 %)
Approved
24680954
DrugRepV_7067Quinine Hydrobromide Hydrate
Antiparasitic products, Insectisides and Repellents
Malaria | Leg cramps
West Nile virus
NA
Pathway
Plaque assay
No significant effect (0 %)
NA
24680954
DrugRepV_7069Amodiaquine derivative (AQD1)
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
Decrease (98 %)
NA
24680954
DrugRepV_7070Amodiaquine derivative (AQD2)
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
24680954
DrugRepV_7071Amodiaquine derivative (AQD3)
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
Decrease (100 %)
NA
24680954
DrugRepV_7072Amodiaquine derivative (AQD4)
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
Decrease (100 %)
NA
24680954
DrugRepV_7073Amodiaquine derivative (AQD5)
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
Decrease (80 %)
NA
24680954
DrugRepV_7074Amodiaquine derivative (AQD6)
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
Decrease (100 %)
NA
24680954
DrugRepV_7075Amodiaquine derivative (AQD7)
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
Decrease (100 %)
NA
24680954
DrugRepV_7076Amodiaquine derivative (AQD8)
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
Decrease (60 %)
NA
24680954
DrugRepV_7077Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
Decrease (50 %)
Approved
24680954
DrugRepV_7078Amodiaquine derivative (AQD1)
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
24680954
DrugRepV_7079Amodiaquine derivative (AQD2)
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
24680954
DrugRepV_7080Amodiaquine derivative (AQD3)
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
24680954
DrugRepV_7081Amodiaquine derivative (AQD4)
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
24680954
DrugRepV_7082Amodiaquine derivative (AQD5)
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
24680954
DrugRepV_7083Amodiaquine derivative (AQD6)
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
24680954
DrugRepV_7084Amodiaquine derivative (AQD7)
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
24680954
DrugRepV_7085Amodiaquine derivative (AQD8)
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
24680954
DrugRepV_7087Chloroquine Mustard
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
24680954
DrugRepV_7088Chloroquine ethyl phenyl Mustard
Antiparasitic products, Insectisides and Repellents
Malaria
West Nile virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
24680954
DrugRepV_7102Ivermectin
Antiparasitic products, Insectisides and Repellents
Intestinal strongyloidiasis | Onchocerciasis
Yellow fever virus
17D
Pathway
Plaque assay
Decrease (5.3 Log)
Approved, Investigational, Vet approved
26752081
DrugRepV_7264Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Japanese encephalitis virus
Nakayama
Pathway
Flow cytometry
Decrease (85 %)
Investigational
16309754
DrugRepV_7337Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Japanese encephalitis virus
P3
Pathway
Plaque assay
Decrease (2 log %)
Approved
24348901
DrugRepV_7340Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Japanese encephalitis virus
P3
Pathway
Immunoflourescence assay
Decrease (30 %)
Approved
24348901
DrugRepV_7343Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Japanese encephalitis virus
P3
Pathway
Luminescence assay
Decrease (50 %)
Approved
24348901
DrugRepV_7475Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
West Nile virus
New York
Pathway
Visual assay
Decrease (50 %)
Investigational
12076755
DrugRepV_7476Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
West Nile virus
Uganda strain B 956
Pathway
Visual assay
Decrease (50 %)
Investigational
12076755
DrugRepV_7478Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
West Nile virus
New York
Pathway
NR assay
Decrease (50 %)
Investigational
12076755
DrugRepV_7479Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
West Nile virus
Uganda strain B 956
Pathway
NR assay
Decrease (50 %)
Investigational
12076755
DrugRepV_7534Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
C-Tan-nCoV Wuhan strain 01
NA
RT-PCR
Decrease (50 %)
Approved
32150618
DrugRepV_7535Hydroxychloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
C-Tan-nCoV Wuhan strain 01
NA
RT-PCR
Decrease (50 %)
Approved
32150618
DrugRepV_7536Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
SARS Coronavirus-2
?CoV/KOR/KCDC03/2020)
NA
Immunofluorescence
Decrease (50 %)
Approved
32438446
DrugRepV_7537Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
SARS Coronavirus-2
?CoV/KOR/KCDC03/2020)
NA
Immunofluorescence
Decrease (90 %)
Approved
32438446
DrugRepV_7543Hydroxychloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
C-Tan-nCoV Wuhan strain 01
NA
RT-PCR
Decrease (50 %)
Approved
32438446
DrugRepV_7544Hydroxychloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
C-Tan-nCoV Wuhan strain 01
NA
RT-PCR
Decrease (90 %)
Approved
32438446
DrugRepV_7546Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
Wuhan/WIV04/2022
NA
qRT-PCR/ NP expression/Immunofluorescence
Decrease (50 %)
Approved
32438446
DrugRepV_7547Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
Wuhan/WIV04/2022
NA
qRT-PCR/ NP expression/Immunofluorescence
Decrease (90 %)
Approved
32438446
DrugRepV_7552Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
SARS Coronavirus-2
Wuhan/WIV04/2020
NA
qRT-PCR/ NP expression/Immunofluorescence
Decrease (50 %)
Approved, Investigational, Vet approved
32438446
DrugRepV_7553Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
SARS Coronavirus-2
Wuhan/WIV04/2020
NA
qRT-PCR/ NP expression/Immunofluorescence
Decrease (90 %)
Approved, Investigational, Vet approved
32438446
DrugRepV_7566Mefloquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
?CoV/KOR/KCDC03/2020)
NA
Immunofluorescence
Decrease (50 %)
Approved, Investigational
32438446
DrugRepV_7567Mefloquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
?CoV/KOR/KCDC03/2020)
NA
Immunofluorescence
Decrease (90 %)
Approved, Investigational
32438446
DrugRepV_7569Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
C-Tan-nCoV Wuhan strain 01
NA
RT-PCR
Decrease (50 %)
Approved
32438446
DrugRepV_7570Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
C-Tan-nCoV Wuhan strain 01
NA
RT-PCR
Decrease (90 %)
Approved
32438446
DrugRepV_7571Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
?CoV/KOR/KCDC03/2020)
NA
Immunofluorescence
Decrease (50 %)
Approved
32438446
DrugRepV_7572Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
?CoV/KOR/KCDC03/2020)
NA
Immunofluorescence
Decrease (90 %)
Approved
32438446
DrugRepV_7579Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
WA-1 strain - BEI ; NR-52281
NA
Plaque assay / TCID50/ qRT-PCR
Decrease (50 %)
Approved
32438446
DrugRepV_7580Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
WA-1 strain - BEI ; NR-52281
NA
Plaque assay / TCID50/ qRT-PCR
Decrease (90 %)
Approved
32438446
DrugRepV_7581Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
?CoV/KOR/KCDC03/2020)
NA
Immunofluorescence
Decrease (50 %)
Approved
32438446
DrugRepV_7582Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
?CoV/KOR/KCDC03/2020)
NA
Immunofluorescence
Decrease (90 %)
Approved
32438446
DrugRepV_7583Amodiaquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
WA-1 strain - BEI ; NR-52282
NA
Plaque assay / TCID50/ qRT-PCR
Decrease (50 %)
Approved
32438446
DrugRepV_7584Ivermectin
Antiparasitic products, Insectisides and Repellents
Intestinal strongyloidiasis | Onchocerciasis
SARS Coronavirus-2
Australia/VIC01/2020 isolate)
NA
RT-PCR
Decrease (50 %)
Approved, Investigational, Vet approved
32438446
DrugRepV_7585Ivermectin
Antiparasitic products, Insectisides and Repellents
Intestinal strongyloidiasis | Onchocerciasis
SARS Coronavirus-2
Australia/VIC01/2020 isolate)
NA
RT-PCR
Decrease (90 %)
Approved, Investigational, Vet approved
32438446
DrugRepV_7596Mefloquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
WA-1 strain - BEI ; NR-52281
NA
Plaque assay / TCID50/ qRT-PCR
Decrease (50 %)
Approved, Investigational
32438446
DrugRepV_7597Mefloquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
WA-1 strain - BEI ; NR-52281
NA
Plaque assay / TCID50/ qRT-PCR
Decrease (90 %)
Approved, Investigational
32438446
DrugRepV_7608Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
?CoV/KOR/KCDC03/2020)
NA
Cytopathic effect (CPE) assay
Decrease (50 %)
Approved
32438446
DrugRepV_7609Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
?CoV/KOR/KCDC03/2020)
NA
Cytopathic effect (CPE) assay
Decrease (90 %)
Approved
32438446
DrugRepV_7615Hydroxychloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
WA-1 strain - BEI ; NR-52290
NA
Plaque assay / TCID50/ qRT-PCR
Decrease (50 %)
Approved
32438446
DrugRepV_7616Hydroxychloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
WA-1 strain - BEI ; NR-52290
NA
Plaque assay / TCID50/ qRT-PCR
Decrease (90 %)
Approved
32438446
DrugRepV_7654Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
WA-1 strain - BEI ; NR-52285
NA
Plaque assay / TCID50/ qRT-PCR
Decrease (50 %)
Approved
32438446
DrugRepV_7663Hydroxychloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
NA
NA
Decrease (50 %)
Approved
32344449
DrugRepV_7672Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
NA
NA
Cytopathic effect (CPE) assay
Decrease (50 %)
Approved
32511355
DrugRepV_7674Mefloquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
NA
Cytopathic effect (CPE) assay
Decrease (50 %)
Approved, Investigational
32511355
DrugRepV_7675Hydroxychloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
NA
Cytopathic effect (CPE) assay
Decrease (50 %)
Approved
32511355
DrugRepV_7688Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
SARS Coronavirus-2
NA
NA
Decrease (50 %)
Approved
32577649
DrugRepV_7779Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
SARS Coronavirus-2
NA
NA
NA
Decrease (50 %)
Approved
32687696
DrugRepV_7780Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
NA
NA
NA
Decrease (50 %)
Approved
32687696
DrugRepV_7781Hydroxychloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
NA
NA
NA
Decrease (50 %)
Approved
32687696
DrugRepV_7782Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
nCoV-2019BetaCoV/Wuhan/WIV04/2019
NA
qRT-PCR
Decrease (50 %)
Approved
32194981
DrugRepV_7783Hydroxychloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
nCoV-2019BetaCoV/Wuhan/WIV04/2019
NA
qRT-PCR
Decrease (50 %)
Approved
32194981
DrugRepV_7786Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
SARS Coronavirus-2
SARS-CoV-2/Leiden-0002
NA
qRT-PCR
Decrease (50 %)
Investigational
32513797
DrugRepV_7809Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Severe acute respiratory syndrome coronavirus
NA
NA
NA
Decrease (50 %)
Approved
17663539
DrugRepV_7811Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Middle East respiratory syndrome coronavirus
NA
NA
Luciferase assay
Decrease (50 %)
Approved, Investigational, Vet approved
32725286
DrugRepV_7812Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Middle East respiratory syndrome coronavirus
NA
NA
Luciferase assay
Decrease (50 %)
Approved, Investigational, Vet approved
32725286
DrugRepV_7976Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Chikungunya virus
S2.1
NA
CPE reduction assay
Decrease (50 %)
Investigational
32191995
DrugRepV_7977Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Chikungunya virus
S2.2
NA
CPE reduction assay
Decrease (50 %)
Investigational
32191995
DrugRepV_7978Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Chikungunya virus
S2.3
NA
CPE reduction assay
Decrease (50 %)
Investigational
32191995
DrugRepV_7979Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Chikungunya virus
S3
NA
CPE reduction assay
Decrease (50 %)
Investigational
32191995
DrugRepV_7980Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Chikungunya virus
S4.1
NA
CPE reduction assay
Decrease (50 %)
Investigational
32191995
DrugRepV_7981Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Chikungunya virus
S4.3
NA
CPE reduction assay
Decrease (50 %)
Investigational
32191995
DrugRepV_7982Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Chikungunya virus
S5
NA
CPE reduction assay
Decrease (50 %)
Investigational
32191995
DrugRepV_7983Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Chikungunya virus
S7
NA
CPE reduction assay
Decrease (50 %)
Investigational
32191995
DrugRepV_7984Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Chikungunya virus
S8
NA
CPE reduction assay
Decrease (50 %)
Investigational
32191995
DrugRepV_7985Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Chikungunya virus
S9
NA
CPE reduction assay
Decrease (50 %)
Investigational
32191995
DrugRepV_8134Niclosamide
Antiparasitic products, Insectisides and Repellents
Tapeworm and intestinal fluke infections | Helminthiasis
Vaccinia virus
NA
Pathway
NA
Decrease (43.7 %)
Approved
32708182
DrugRepV_8334Hydroxychloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
SARS Coronavirus-2
Experimental
NA
Viral inhibition assay
Decrease (50 %)
Approved
32285930